OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM

Market cap $34.2M

Overview Fund Activity

25.93 USD

+0.13

0.5%

At close Updated Sep 16, 9:30 AM EDT

1 day

0.5%

5 days

0.15%

1 month

1.01%

3 months

-2.34%

6 months

4.77%

Year to date

6.14%

1 year

-9.68%

5 years

2.21%

10 years

2.21%

0

Funds holding %

of 7,463 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

5.48% less ownership

Funds ownership: 21.11% [Q1] → 15.63% (-5.48%) [Q2]

20% less funds holding

Funds holding: 15 [Q1] → 12 (-3) [Q2]

34% less capital invested

Capital invested by funds: $7.83M [Q1] → $5.2M (-$2.64M) [Q2]

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $232K

See Fund Rankings

Financial journalist opinion

Zacks Investment Research

Inside Last Week's Wall Street Rally & Best-Performing ETF Areas

Wall Street soared last week as strong jobs data and easing trade tensions sparked market optimism.

Inside Last Week's Wall Street Rally & Best-Performing ETF Areas

Zacks Investment Research

5 Sector ETFs Up 10% Despite February's Market Slump

The U.S. stocks disappointed investors in Feb amid slowdown concerns and tariffs. These ETFs still gained in double digits.

5 Sector ETFs Up 10% Despite February's Market Slump

New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs

For many of us, a new year often means a new chance to start fresh in our battle with weight. Thanks to interesting ETF product development, especially in the past year, it could also mean a chance to consider the investment opportunity in weight loss as a theme.

New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs

Disruptive Theme of the Week: 2024's Top Investment Themes & Trends

2024 was an amazing year for investment performance, with the broad market S&P 500 TR Index up over 28%. There were also some serious ETF milestones achieved this year.

Disruptive Theme of the Week: 2024's Top Investment Themes & Trends

Disruptive Theme of the Week – Breakthroughs in Medicine

Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical breakthroughs and developments and explore a few ways to get actionable exposure to them with ETFs.

Disruptive Theme of the Week – Breakthroughs in Medicine

Disruptive Theme of the Week: Happy Post-Election Themes

With the completion of a close presidential election, roughly half of us are likely disappointed regardless of the winner. To counter the post-election blues, I identified some “happy” ETF themes to consider for investment.

Disruptive Theme of the Week: Happy Post-Election Themes

Zacks Investment Research

Tap the Weight-Loss Drug Market With These ETFs

Investors seeking to tap the boom in weight-loss drug treatment could consider these ETFs.

Tap the Weight-Loss Drug Market With These ETFs

CNBC Television

Mag7, AI and GLP-1: Roundhill CEO on the hottest ETFs to watch

Dave Mazza, Roundhill Investments CEO, joins CNBC's Bob Pisani on “Halftime Report's” “ETF Edge” segment to discuss the firms' three ETFs following the Mag7, AI and GLP-1 themes.

Disruptive Theme of the Week: Playing Defense

When markets correct, it is a good time to revisit which equity market sectors are “defensive” themes. Certain products and services are nondiscretionary in nature that we cannot live without.

Disruptive Theme of the Week: Playing Defense

Zacks Investment Research

ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment

Two companies, Eli Lilly (LLY) and Novo Nordisk (NVO), have so far dominated the weight-loss drug market. Now, Roche recently announced encouraging Phase I trial data for its new obesity drug candidate.

ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment

See News Rankings

Charts implemented using Lightweight Charts™